Connection

Robert Haile to Registries

Back to Details
This is a "connection" page, showing publications Robert Haile has written about Registries.
Robert Haile
Connection Strength
2.045
Registries
  1. Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry. BMC Cancer. 2018 May 05; 18(1):532.
    View in: PubMed
    Score: 0.116
  2. Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol. 2018 04 01; 47(2):387-388i.
    View in: PubMed
    Score: 0.115
  3. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018 01 01; 36(1):25-33.
    View in: PubMed
    Score: 0.112
  4. Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012. J Invest Dermatol. 2017 11; 137(11):2282-2290.
    View in: PubMed
    Score: 0.110
  5. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol. 2015 May; 1(2):214-21.
    View in: PubMed
    Score: 0.094
  6. Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PLoS One. 2013; 8(4):e60464.
    View in: PubMed
    Score: 0.082
  7. A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila). 2012 Feb; 5(2):150-63.
    View in: PubMed
    Score: 0.075
  8. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35.
    View in: PubMed
    Score: 0.074
  9. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn. 2011 May; 13(3):271-81.
    View in: PubMed
    Score: 0.071
  10. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010 Apr 01; 16(7):2214-24.
    View in: PubMed
    Score: 0.066
  11. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):525-36.
    View in: PubMed
    Score: 0.065
  12. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):89-100.
    View in: PubMed
    Score: 0.065
  13. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control. 2010 Apr; 21(4):597-608.
    View in: PubMed
    Score: 0.065
  14. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol Genet Metab. 2010 Feb; 99(2):157-9.
    View in: PubMed
    Score: 0.064
  15. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2331-43.
    View in: PubMed
    Score: 0.056
  16. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
    View in: PubMed
    Score: 0.031
  17. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018 11 01; 143(9):2250-2260.
    View in: PubMed
    Score: 0.030
  18. Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA Oncol. 2018 Mar 01; 4(3):317-323.
    View in: PubMed
    Score: 0.029
  19. Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer. 2017 06; 108:140-149.
    View in: PubMed
    Score: 0.027
  20. Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):366-375.
    View in: PubMed
    Score: 0.026
  21. Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. PLoS One. 2016; 11(7):e0157521.
    View in: PubMed
    Score: 0.026
  22. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer. 2016 10 01; 139(7):1557-63.
    View in: PubMed
    Score: 0.025
  23. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study. Int J Cancer. 2016 Sep 01; 139(5):1081-90.
    View in: PubMed
    Score: 0.025
  24. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol. 2016 06; 45(3):940-53.
    View in: PubMed
    Score: 0.025
  25. Determining the familial risk distribution of colorectal cancer: a data mining approach. Fam Cancer. 2016 Apr; 15(2):241-51.
    View in: PubMed
    Score: 0.025
  26. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort. BMJ Open. 2016 Feb 19; 6(2):e010293.
    View in: PubMed
    Score: 0.025
  27. Childhood cancers in families with and without Lynch syndrome. Fam Cancer. 2015 Dec; 14(4):545-51.
    View in: PubMed
    Score: 0.025
  28. Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden. Breast Cancer Res Treat. 2015 Nov; 154(2):369-75.
    View in: PubMed
    Score: 0.024
  29. Lynch syndrome and cervical cancer. Int J Cancer. 2015 Dec 01; 137(11):2757-61.
    View in: PubMed
    Score: 0.024
  30. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.024
  31. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):601-10.
    View in: PubMed
    Score: 0.022
  32. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014 May; 146(5):1208-11.e1-5.
    View in: PubMed
    Score: 0.022
  33. Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Fam Cancer. 2013 Sep; 12(3):563-6.
    View in: PubMed
    Score: 0.021
  34. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut. 2014 May; 63(5):800-7.
    View in: PubMed
    Score: 0.021
  35. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control. 2013 Aug; 24(8):1605-14.
    View in: PubMed
    Score: 0.021
  36. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev. 2013 Jul; 22(7):1239-51.
    View in: PubMed
    Score: 0.020
  37. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012 Oct 17; 308(15):1555-65.
    View in: PubMed
    Score: 0.020
  38. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat. 2013 Jan; 34(1):200-9.
    View in: PubMed
    Score: 0.020
  39. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012 Sep 19; 104(18):1363-72.
    View in: PubMed
    Score: 0.020
  40. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut. 2013 Feb; 62(2):272-9.
    View in: PubMed
    Score: 0.019
  41. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut. 2012 Sep; 61(9):1299-305.
    View in: PubMed
    Score: 0.018
  42. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
    View in: PubMed
    Score: 0.018
  43. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010 Dec 01; 127(11):2678-84.
    View in: PubMed
    Score: 0.017
  44. Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010 Aug; 19(8):2023-34.
    View in: PubMed
    Score: 0.017
  45. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010 Jul 21; 102(14):1012-22.
    View in: PubMed
    Score: 0.017
  46. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis. 2010 Aug; 31(8):1412-6.
    View in: PubMed
    Score: 0.017
  47. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
    View in: PubMed
    Score: 0.016
  48. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
    View in: PubMed
    Score: 0.016
  49. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2745-50.
    View in: PubMed
    Score: 0.016
  50. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3208-15.
    View in: PubMed
    Score: 0.015
  51. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1411-8.
    View in: PubMed
    Score: 0.014
  52. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res. 2007 Dec 01; 67(23):11128-32.
    View in: PubMed
    Score: 0.014
  53. Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):906-11.
    View in: PubMed
    Score: 0.014
  54. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res. 2004; 6(3):R199-214.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.